Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann T Farrell

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2018
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid LeukemiaAviva C Krauss, Xin Gao, Liang Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2015
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell LymphomaHyon-Zu Lee, Virginia E Kwitkowski, Pedro L Del Valle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Approval summary for bortezomib for injection in the treatment of multiple myelomaPeter F Bross, Robert Kane, Ann T Farrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2015
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic LeukemiaR Angelo de Claro, Karen M McGinn, Nicole Verdun, et al.
Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settingsAnn T Farrell, Julie Panepinto, Ankit A Desai, et al.
Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brainAnn T Farrell, Julie Panepinto, C Patrick Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2017
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future ApplicationsKenneth C Anderson, Daniel Auclair, Gary J Kelloff, et al.
Academic Radiology|February 20, 2007
FDG-PET lymphoma demonstration project invitational workshopGary J Kelloff, Daniel M Sullivan, Wyndham Wilson, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2018
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid LeukemiaAviva C Krauss, Xin Gao, Liang Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2015
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell LymphomaHyon-Zu Lee, Virginia E Kwitkowski, Pedro L Del Valle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Approval summary for bortezomib for injection in the treatment of multiple myelomaPeter F Bross, Robert Kane, Ann T Farrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2015
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic LeukemiaR Angelo de Claro, Karen M McGinn, Nicole Verdun, et al.
Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settingsAnn T Farrell, Julie Panepinto, Ankit A Desai, et al.
Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brainAnn T Farrell, Julie Panepinto, C Patrick Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2017
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future ApplicationsKenneth C Anderson, Daniel Auclair, Gary J Kelloff, et al.
Academic Radiology|February 20, 2007
FDG-PET lymphoma demonstration project invitational workshopGary J Kelloff, Daniel M Sullivan, Wyndham Wilson, et al.
Pageof 6